Offer - Urjas Oil for just ₹ 1 X
Olmesafe 10 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP. Olmesafe 10 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Olmesafe 10 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Olmesafe 10 Tablet include Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmesafe 10 Tablet as well, which are listed below. Usually, these side effects of Olmesafe 10 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olmesafe 10 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Olmesafe 10 Tablet related warnings talks about Olmesafe 10 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) must refrain from the use of Olmesafe 10 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Olmesafe 10 Tablet contraindications section.
Drug interactions for Olmesafe 10 Tablet have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Olmesafe 10 Tablet is considered not safe while driving, and is not addictive.
Olmesafe 10 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Olmesafe 10 Tablet safe for pregnant women?
Olmesafe should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olmesafe 10 Tablet safe during breastfeeding?
Side effects of Olmesafe for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Olmesafe 10 Tablet on the Kidneys?
Olmesafe has very mild side effects on the kidneys.
What is the effect of Olmesafe 10 Tablet on the Liver?
Olmesafe has very mild side effects on the liver.
What is the effect of Olmesafe 10 Tablet on the Heart?
Olmesafe is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Olmesafe 10 Tablet unless your doctor advises you to do so -
Is this Olmesafe 10 Tablet habit forming or addictive?
No, there is no any evidence that Olmesafe 10 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olmesafe 10 Tablet, you should not drive or work on any heavy machine, as Olmesafe 10 Tablet can make you drowsy.
Is it safe?
Yes, but take Olmesafe 10 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Olmesafe 10 Tablet is not used to treat mental disorders.
Interaction between Food and Olmesafe 10 Tablet
Some foods when eaten with Olmesafe 10 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmesafe 10 Tablet
Consumption of alcohol and Olmesafe 10 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173